Kfar Saba, Israel

Shai Yarkoni

This inventor holds 10 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., Cellect Biotherapeutics Ltd., Other. Active years: 2000-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shai Yarkoni. Retrieved from https://idiyas.com/inventor/shai-yarkoni

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 10 

% Patents Active = 60.0

 

 

Average Co-Inventor Count = 3.0

ph-index = 5

Forward Citations = 63(Granted Patents)


Location History:

  • Kfar-Saba IL (2000)
  • Rehovot, IL (2017)
  • Kfar-Saba, IL (2003 - 2023)

Company Filing History:


Years Active: 2000-2023

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Shai Yarkoni: Innovator in Stem Cell Technology

Introduction

Shai Yarkoni is a prominent inventor based in Kfar Saba, Israel. He has made significant contributions to the field of stem cell technology, holding a total of 10 patents. His work focuses on methods that enhance the propagation and selection of mesenchymal stem cells, which are crucial for various medical applications.

Latest Patents

One of Yarkoni's latest patents is titled "Methods for propagating mesenchymal stem cells (MSC) for use in transplantation." This patent provides methods for propagating MSC, particularly adipose-derived stem cells. The methods involve incubating isolated cells obtained from a tissue or organ in a growth medium that includes an apoptosis-inducing agent under specified conditions. Additionally, he has developed an isolated cell population and kits for performing these methods.

Another notable patent is "Devices and methods for selecting apoptosis-signaling resistant cells, and uses thereof." This invention discloses a device and kit designed for the selection of cells resistant to receptor-mediated apoptosis. The method allows for the negative selection of mature immune cells that can induce graft versus host disease (GvHD) from a heterogeneous cell population. This device enables efficient cell selection in a simplified and cost-effective manner, utilizing an off-the-shelf product that is currently unavailable in the market.

Career Highlights

Throughout his career, Shai Yarkoni has worked with several notable companies, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Cellect Biotherapeutics Ltd. His innovative work has positioned him as a key figure in the advancement of stem cell research and applications.

Collaborations

Yarkoni has collaborated with several professionals in his field, including Haya Lorberboum-Galski and Irina Marianovsky. These collaborations have further enriched his research and development efforts.

Conclusion

Shai Yarkoni's contributions to stem cell technology through his patents and collaborations highlight his role as an influential inventor in the medical field. His innovative methods and devices are paving the way for advancements in transplantation and cell therapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…